Clovis Oncology (CLVS) Reports Q3 Loss, Lags Revenue Estimates

Published on 9 Nov 2022 on Zacks via Yahoo Finance

Clovis Oncology (CLVS) Reports Q3 Loss, Lags Revenue Estimates

Clovis Oncology (CLVS) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.42. This compares to loss of $0.56 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of 7.14%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of $0.42 per share when it actually produced a loss of $0.43, delivering a surprise of -2.38%.

Over the last four quarters, the company has surpassed consensus EPS estimates two times.

Read the rest of the article

Want to become a better investor?

Start tracking your investments with Statfolio

Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session...

Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session

Investing.com 13 Dec 2022

Boulder drugmaker Clovis Oncology files for bankruptcy - Denver Business Journal

The public company reported that its assets were about $320 million, while its estimated liabilit...

The Business Journals 12 Dec 2022

Clovis (CLVS) Files for Bankruptcy Amid Lack of Financial Aid

Clovis Oncology, Inc. CLVS announced that the company and some of its subsidiaries initiated volu...

Zacks via Yahoo Finance 12 Dec 2022

Clovis Enters Bankruptcy With Deal to Sell Cancer-Drug Candidate to Novartis

Clovis Oncology, maker of ovarian cancer drug Rubraca, has filed for chapter 11 and proposed sell...

The Wall Street Journal 12 Dec 2022

Clovis Plans to Sell Cancer Drug to Novartis in Bankruptcy Deal

(Bloomberg) -- Clovis Oncology Inc. filed for bankruptcy and plans to sell its experimental cance...

Bloomberg via Yahoo Finance 12 Dec 2022

Clovis (CLVS) Stock Down 50% in the Past 6 Months: Here's Why

Clovis Oncology, Inc.’s CLVS shares have plunged 49.6% in the past six months against the industr...

Zacks via Yahoo Finance 26 Nov 2022

Clovis (CLVS) Plummets on News of Possible Bankruptcy Filing

Shares of Clovis Oncology CLVS plunged 71.6% after the company announced that it will not have su...

Zacks via Yahoo Finance 10 Nov 2022

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.95% By Investing.com

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.95%

Investing.com 9 Nov 2022

Clovis Oncology (CLVS) Reports Q3 Loss, Lags Revenue Estimates

Clovis Oncology (CLVS) came out with a quarterly loss of $0.39 per share versus the Zacks Consens...

Zacks via Yahoo Finance 9 Nov 2022

Clovis Oncology stock slides 75% after biotech warns it will run out of cash by January of 2023

Clovis Oncology Inc. shares plunged 75% Wednesday, after the Colorado-based biotech said it will ...

MarketWatch 9 Nov 2022